InsulinGlargineQualityChecker
Insulin Glargine
Insulin Glargine Quality Checker — Biologic Drug (Long-acting Insulin Analog) (Ph. Eur., USP)
ℹ️ The utility checks potency, proinsulin, aggregates, zinc, pH (acidic), sterility, endotoxins.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! Proinsulin ≤10 ppm, Aggregates ≤0.5%, pH 3.8-4.2, Sterility mandatory!
Usage:
InsulinGlargineQualityChecker.exe → demo mode
InsulinGlargineQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,Protein_Concentration_mgPerMl,Potency_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Zinc_Content_Percent,Proinsulin_Content_ppm,Related_Proteins_Percent,High_Molecular_Weight_Proteins_Percent,Residual_DNA_ngPerMl,Host_Cell_Protein_ppm,SterilityTest,Endotoxin_EU_ml,Appearance_Score,Meta_Cresol_Content_Percent
Example:
INS-GLA-2026-001,3.64,27.0,100.0,4.0,0.04,2.0,0.3,0.1,1.0,2.0,0,0.02,0,0.30
— WHY IS THIS NEEDED?
Insulin Glargine — long-acting human insulin analog (AsnA21 replaced by Gly, Arg added at B30-B32):
• Potency (IU): Key efficacy parameter. Determined by bioassay.
• Proinsulin: Precursor. Causes antibody formation. Limit is extremely strict (<10 ppm).
• Aggregates (HMW): High molecular weight proteins cause immune response.
• Zinc: Critical for mechanism of action. In acidic solution (pH 4), insulin is soluble. Upon SC injection (neutral pH), zinc facilitates micro-precipitate formation, slowly releasing insulin.
• pH: Solution must be acidic (pH ~4.0) to maintain solubility before injection.
• Sterility and Endotoxins: Absolutely mandatory.
⚠️ CRITICAL:
• Protein Concentration: 3.5–3.8 mg/mL (for U-100)
• Specific Potency: 26–28 IU/mg
• Proinsulin: ≤ 10 ppm
• Aggregates (HMW): ≤ 0.5%
• Zinc: 0.03–0.06%
• pH: 3.8–4.2 (strict!)
• Sterility: No growth
• Endotoxins: ≤ 0.5 EU/mL
• Appearance: Clear, colorless
⚠️ Note: Utility accounts for glargine specifics — acidic pH and zinc role in depot formation. pH deviation may lead to premature precipitation in vial or solution instability. Proinsulin and aggregate control are Critical Quality Attributes (CQA). Any sterility deviation leads to rejection.
input.csv
BatchNumber,Protein_Concentration_mgPerMl,Potency_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Zinc_Content_Percent,Proinsulin_Content_ppm,Related_Proteins_Percent,High_Molecular_Weight_Proteins_Percent,Residual_DNA_ngPerMl,Host_Cell_Protein_ppm,SterilityTest,Endotoxin_EU_ml,Appearance_Score,Meta_Cresol_Content_Percent INS-GLA-2026-001,3.64,27.0,100.0,4.0,0.04,2.0,0.3,0.1,1.0,2.0,0,0.02,0,0.30
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Insulin Glargine Quality Checker utility is used for Insulin Glargine. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API
Tags: API, assay, biologics, biosimilars, endotoxins, fixed-dose combinations, generics, injectables, market map, sterility
2. Execution modes
InsulinGlargineQualityChecker.exe → demo mode InsulinGlargineQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- purity and impurities
- microbiology and pathogens
- pH and physicochemical parameters
4. Domain limits and critical parameters
- ⚠️ CRITICAL! Proinsulin ≤10 ppm, Aggregates ≤0.5%, pH 3.8-4.2, Sterility mandatory!
- Proinsulin: Precursor. Causes antibody formation. Limit is extremely strict (<10 ppm).
- ⚠️ CRITICAL:
- Protein Concentration: 3.5–3.8 mg/mL (for U-100)
- Specific Potency: 26–28 IU/mg
- Proinsulin: ≤ 10 ppm
- Aggregates (HMW): ≤ 0.5%
- Zinc: 0.03–0.06%
- pH: 3.8–4.2 (strict!)
- Sterility: No growth
- Endotoxins: ≤ 0.5 EU/mL
- Appearance: Clear, colorless
- ⚠️ Note: Utility accounts for glargine specifics — acidic pH and zinc role in depot formation. pH deviation may lead to premature precipitation in vial or solution instability. Proinsulin and aggregate control are Critical Quality Attributes (CQA). Any sterility deviation leads to rejection.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Insulin Glargine with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, purity and impurities, microbiology and pathogens, pH and physicochemical parameters. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | INS-GLA-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Protein_Concentration_mgPerMl | decimal | mg/ml | Protein Concentration mg per Ml | 3.64 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Potency_IU_per_mg | decimal | as specified | Potency IU per mg | 27.0 | mandatory numeric value; rule comparison is performed by the utility |
| 4 | Total_Potency_IU_per_ml | decimal | IU/ml | Total Potency IU per ml | 100.0 | mandatory numeric value; rule comparison is performed by the utility |
| 5 | pH_Value | decimal | pH | p H Value | 4.0 | mandatory numeric value; rule comparison is performed by the utility |
| 6 | Zinc_Content_Percent | decimal | % | Zinc Content % | 0.04 | numeric value; compared with assay/purity limit from specification or method |
| 7 | Proinsulin_Content_ppm | decimal | ppm | Proinsulin Content ppm | 2.0 | numeric value; compared with assay/purity limit from specification or method |
| 8 | Related_Proteins_Percent | decimal | % | Related Proteins % | 0.3 | numeric value; compared with individual or total impurity limit |
| 9 | High_Molecular_Weight_Proteins_Percent | decimal | % | High Molecular Weight Proteins % | 0.1 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | Residual_DNA_ngPerMl | decimal | as specified | Residual DNA ng per Ml | 1.0 | mandatory numeric value; rule comparison is performed by the utility |
| 11 | Host_Cell_Protein_ppm | decimal | ppm | Host Cell Protein ppm | 2.0 | mandatory numeric value; rule comparison is performed by the utility |
| 12 | SterilityTest | boolean / flag | 0/1 | Sterility Test | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 13 | Endotoxin_EU_ml | decimal | as specified | Endotoxin EU ml | 0.02 | numeric value; critical safety attribute compared with endotoxin limit |
| 14 | Appearance_Score | decimal | as specified | Appearance Score | 0 | mandatory numeric value; rule comparison is performed by the utility |
| 15 | Meta_Cresol_Content_Percent | decimal | % | Meta Cresol Content % | 0.30 | numeric value; compared with assay/purity limit from specification or method |
CSV example
BatchNumber,Protein_Concentration_mgPerMl,Potency_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Zinc_Content_Percent,Proinsulin_Content_ppm,Related_Proteins_Percent,High_Molecular_Weight_Proteins_Percent,Residual_DNA_ngPerMl,Host_Cell_Protein_ppm,SterilityTest,Endotoxin_EU_ml,Appearance_Score,Meta_Cresol_Content_Percent INS-GLA-2026-001,3.64,27.0,100.0,4.0,0.04,2.0,0.3,0.1,1.0,2.0,0,0.02,0,0.30
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable InsulinGlargineQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Insulin Glargine, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "InsulinGlargineQualityChecker",
"api": "Insulin Glargine",
"batchNumber": "INS-GLA-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "INS-GLA-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Protein_Concentration_mgPerMl",
"value": "3.64",
"unit": "mg/ml",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Potency_IU_per_mg",
"value": "27.0",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Total_Potency_IU_per_ml",
"value": "100.0",
"unit": "IU/ml",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH_Value",
"value": "4.0",
"unit": "pH",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Zinc_Content_Percent",
"value": "0.04",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Proinsulin_Content_ppm",
"value": "2.0",
"unit": "ppm",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Related_Proteins_Percent",
"value": "0.3",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenArgentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenAustralia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBiopharmaceuticals Core QC Suite
Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.
OpenBiopharmaceuticals Extended QC Suite
Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.
OpenBrazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenChina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenColombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDemocratic Republic of the Congo: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDiabetes QC Suite
QC package for diabetes medicines: insulins, metformin, SGLT2/DPP-4/GLP-1 products, glucagon and supporting dosage-form quality checks.
OpenEgypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEndocrinology QC Suite
QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.
OpenEthiopia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGlobal API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenImmunology QC Suite
QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.
OpenIndia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndonesia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenKenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMyanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenNigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPhilippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Africa: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSudan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTanzania: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenThailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTurkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenVietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Open